Come up with a name for your new list and we'll add to it:
Presidio Pharmaceuticals raised a round of funding on July 25, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. Presidio's focus is on effective therapies for …